Content area
Abstract
Aegera Therapeutics Inc., Affibody, Alimentary Health Ltd, Alphora Research Inc., Aspreva Pharmaceuticals, Athenagen, Avid Bioservices, Axela Biosensors Inc., BioWa, Inc., Cell Genesys, Inc., Celldex Therapeutics, Centre for Translational and Applied Genomics, ChemokineTherapeutics, CombinatoRx, Cytokinetics, Inc., enGene, Epeius Biotechnologies Corporation, F2G Limited, Forbes Medi-Tech Inc., Hunter-Fleming Limited, Ichor Medical Systems, Inc., ICPbio Limited, Ingenium Pharmaceuticals AG, Inimex Pharmaceuticals, Inc., InNexus Biotechnology Inc., KAI Pharmaceuticals, MaxCyte, Inc., NAL Pharmaceuticals Ltd, NascaCell Technologies AG, NovaDel Pharma, Novation, NPIL Pharma Torcan, Orphan Australia Pty Ltd, Patheon Inc., PIERIS AG, Resverlogix Corp., SemBioSys, SR Pharma plc. / Atugen AG, Stem Cell Therapeutics, Syntaxin, Trigen Holdings AG, Tripos Discovery Research, Vertical i, Inc., Virxsys Corporation, Welichem Biotech Inc., XOMA Ltd., Xytis, ZIOPHARM Oncology, Inc.
TVG is excited to offer video profiles to presenting companies at BPN 2007. This exciting feature gives Open House and Emerging Company presenters the ability to add a short video to their biopartnering.com profile and thus promote their company in a dynamic and engaging manner. This additional video capability within biopartnering.com demonstrates BPN's commitment to finding new ways to showcase companies, and reaffirms biopartnering.com's position as the leading life science conference collaboration tool, enabling BPN presenters to achieve maximum effectiveness from their conference experience.